INTRODUCTION Mutations in Presenilin (PS) 1 and 2 cause familial Alzheimer’s Disease (AD) through undetermined mechanisms. PS’s are intramembranous aspartyl.

Slides:



Advertisements
Similar presentations
Effect of Liraglutide Treatment on Inflammation and Oxidative Stress in Young and Old APP/PS1 and WT Mice Supervisors: Dr. Christian Holscher Dr. Kerry.
Advertisements

Disregulation of Akt Associated with Enhanced Cardiotoxicity in ß2-Adrenergic Receptor (AR) Knockout Mice: Possible Mechanism of Crosstalk Between ß-Receptors.
This is only for personal educational purposes.
ALZHEIMER’S DISEASE Erin Dancey. Overview Alzheimer’s is the most common cause of dementia in adult life and is associated with the selective damage of.
ALZHEIMER'S DISEASE (AD)
Comparison of Plaque Burden in Tg2576 Mice Using the Aperio and TurboScan Imaging Platforms A.J. Milici.
(+++) Normal breast ATM (++) IDC ATM Lymph node metastasis negative positive P-value A B X200 C Vector ATM - WT.
Soluble Epoxide Hydrolase Inhibitor Reduces Neuronal Death and NF-kB Activation after Cardiac Arrest Department of Anesthesiology & Perioperative.
and Hippocampal Cells in Murine and Human AD Brains
Amnesia Syndromes Lesson 22. Wernicke-Korsakoff’s Syndrome n Deficits similar to H.M. l Anterograde l retrograde more severe n Cause: Long-term alcohol.
A NEUROPEPTIDE THAT DRAMATICALLY ENHANCES LEARNING AND MEMORY POTENTIAL FOR COGNITIVE DRUG DEVELOPMENT John M. Stewart Department of Biochemistry University.
Introduction Alzheimer’s disease (AD) is a neurodegenerative disease associated with brain shrinkage and the loss of neurons, particularly cholinergic.
Molecular mechanism for Alzheimer’s disease : searching for the possible therapeutic targets Sungkwon Chung Dept. of Physiology Sungkyunkwan Univ. School.
Trafficking and processing of APP  and  -secretase.
Dr. Sigal fleisher-Berkovich Neuroinflammation is regulated by angiotensin related drugs: possible implications for neurodegenerative diseases.
Effects of matrix metalloproteinase-9 on insulin survival pathways in Alzheimer’s disease Introduction Defective brain insulin signaling has been suggested.
The aspartyl protease BACE  -Amyloid cleaving enzyme.
Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: The Common Inhalational Anesthetic Sevoflurane Induces.
Adenosine Protects Vascular Barrier Function in Hyperoxic Lung Injury Jonathan Davies 1, Harry Karmouty-Quintana 2, Thuy T. Le 2, Ning-Yuan Chen 2, Tingting.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: SOCS1 Prevents Graft Arteriosclerosis by Preserving.
Presenilin 1/2 and their mutation in Alzheimer Disease
Trends in Biomedical Science Theories of Alzheimer’s Disease.
Date of download: 6/22/2016 Copyright © 2016 American Medical Association. All rights reserved. From: β-Secretase Protein and Activity Are Increased in.
ENDOCANNABINOID REGULATION OF ALTERNATIVE MICROGLIA ACTIVATION IN MULTIPLE SCLEROSIS CAITLIN JAGLA.
10% SDS-PAGE Immunoblot for Epitope H (O-GlcNAcH)
Camara M1, Anscomb H.L. 2 and Baune B.T. 1,2
Volume 2, Issue 12, Pages (December 2015)
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease  Konrad Talbot, Hoau-Yan Wang 
Cerebrovasc Dis 2016;42: DOI: /
Surfactant proteins-A and -D attenuate gut injury and apoptosis
Figure 2. Macrophages in dystrophic muscle in vivo and in vitro express Klotho. (A) A cross-section of 4-week-old mdx muscle labeled with antibodies to.
Interruption of spinal cord microglial signaling by alpha-2 agonist dexmedetomidine in a murine model of delayed paraplegia  Marshall T. Bell, MD, Viktor.
Athena Kalyvas, Samuel David  Neuron 
Methods Objectives Results Conclusions References
D.W Huang, L McKerracher, P.E Braun, S David  Neuron 
Taking Advantage of the Systemic Immune System to Cure Brain Diseases
Growth Hormone Inhibits Signal Transducer and Activator of Transcription 3 Activation and Reduces Disease Activity in Murine Colitis  Xiaonan Han, Danuta.
Hyaluronate-Enhanced Hematopoiesis: Two Different Receptors Trigger the Release of Interleukin-1β and Interleukin-6 From Bone Marrow Macrophages by Sophia.
Jinu Kim, Kelly E. Long, Kang Tang, Babu J. Padanilam 
Volume 56, Issue 1, Pages (October 2007)
Volume 18, Issue 5, Pages (May 2010)
Volume 45, Issue 3, Pages (February 2005)
Great Expectations for PIP: Phosphoinositides as Regulators of Signaling During Development and Disease  Lara C. Skwarek, Gabrielle L. Boulianne  Developmental.
Volume 120, Issue 3, Pages (February 2005)
Volume 78, Issue 4, Pages (May 2013)
Volume 85, Issue 3, Pages (February 2015)
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 58, Issue 6, Pages (June 2008)
Mechanisms Underlying Inflammation in Neurodegeneration
Alzheimer’s Disease Neurobiology
Volume 17, Issue 3, Pages (October 2016)
The cardiomyocyte protein αT-catenin contributes to asthma through regulating pulmonary vein inflammation  Stephen Sai Folmsbee, G.R. Scott Budinger,
Contribution of Src-FAK signaling to the induction of connective tissue growth factor in renal fibroblasts  A. Graness, I. Cicha, M. Goppelt-Struebe 
The pathological role of Bax in cisplatin nephrotoxicity
Syed M. Meeran, Thejass Punathil, Santosh K. Katiyar 
Figure 1 Time-dependent progression of α-synuclein accumulation and aggregation in foetal dopamine nigral grafts. ... Figure 1 Time-dependent progression.
The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiency by Pradeep Bangalore-Prakash, Laura.
Anh Pham Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease.
What is the major conclusion of this paper?
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease  Konrad Talbot, Hoau-Yan Wang 
Effects of PS1 Deficiency on Membrane Protein Trafficking in Neurons
Alzheimer Presenilins in the Nuclear Membrane, Interphase Kinetochores, and Centrosomes Suggest a Role in Chromosome Segregation  Jinhe Li, Min Xu, Hui.
TOMA does not affect NFTs in posterior hypothalamus or cortex.
ErbB4 expression in PV+ and PV– interneurons and the ErbB4 expression levels in hippocampus of WT and the NRG1tg-type-I mice. ErbB4 expression in PV+ and.
Arc/Arg3.1 Mediates Homeostatic Synaptic Scaling of AMPA Receptors
Notch1 signaling mediates the neuronal induction of BLBP promoter transcription in glia. Notch1 signaling mediates the neuronal induction of BLBP promoter.
EGFR signaling and ADAM10 are required for N-cadherin processing.
Fig. 3. KMS99220 inhibits activation of NFκB signaling via HO-1 induction. (A) BV2 cells were treated with 10 µM KMS99220 for 1 h, and then treated with.
Volume 45, Issue 3, Pages (February 2005)
Matrix Metalloproteinase Inhibitor BB-3103 Unlike the Serine Proteinase Inhibitor Aprotinin Abrogates Epidermal Healing of Human Skin Wounds Ex Vivo1 
Presentation transcript:

INTRODUCTION Mutations in Presenilin (PS) 1 and 2 cause familial Alzheimer’s Disease (AD) through undetermined mechanisms. PS’s are intramembranous aspartyl proteases capable of cleaving amyloid precursor protein (APP), however their full function in normal and injured cell physiology is not yet known. PS’s catalyze a growing number of identified substrates by regulated intramembranous proteolysis such as the developmental and cell fate regulator, Notch and the tyrosine kinase receptor ErbB4. PS’s are cleaved into C-terminus (CTF) and N-terminus (NTF) fragments to form an active heterodimer enzyme. Inflammation contributes to the neurodegenerative process in a number of human diseases including AD, Parkinson’s Disease, ALS and HIV Associated Dementia (HAD) PS2 knockout mice have normal APP metabolism yet develop age-related mild pulmonary fibrosis a process associated with chronic inflammation in humans. We hypothesize that PS2 participates in the CNS inflammatory process in human neurodegenerative disease. CONCLUSIONS Microglial PS2 is increased in the human neurodegenerative diseases AD and HIV Associated Dementia. HIV glycoprotein gp120, a known activator of microglia, leads to enhanced expression of PS2 protein. Hypotheses PS2 mediated  -secretase activity or the PS2 holoprotein participates in intracellular signaling processes of microglia activation. Inhibition of PS2  -secretase activity or non-canonical PS2 function can interfere with microglial activation. Presenilin 2 is Upregulated During Microglia Activation S. Jayadev, H. Nguyen and G. Garden Neurology, University of Washington, Seattle Microglia from AD brain express enhanced PS2 AD Control AD Ctrl % PS2 Positive Microglia * B) A) PS2 (brown) strongly labels microglia (purple) in AD brain (arrows) whereas microglia in control brain (arrowheads) do not demonstrate similar PS2 immunopositivity The proportion of microglia demonstrating PS2 immunoreactivity is significantly higher ( * = p<.001) in AD brain compared to control. 5 fields each were counted from 4 AD brains and 4 control brains. 45kDa 4. Cultured microglia and microglia cell lines stimulated with the HIV coat protein gp120 show increased PS2 Microglia treated with gp120 demonstrate a dose dependent increase in cell line PS2 expression on western blot (A). Boiled gp120 (control) does not result in increased PS2 expression (B) HIV/gp120 PS2 actin 50kDa 400pM0 boiled Primary Microglia RAW cells BV-2 cells 200pM00 400pM800pM1000pM 200pM +LPS 50kDa 45kDa PS2 antibody : Calbiochem Loop (1:1000) 50 kDa 25 kDa 37 kDa PS 2 20 kDa PS 2 NTF A) actin gp120 Control gp120 B) actin PS 2 CTF gp120 Control gp PS2 holoprotein, NTF and CTF are all increased in response to gp120 stimulation in primary microglia Western blot analysis using antibody to the PS2 N-terminus demonstrates increased PS2 holoprotein and N-terminus after gp120 stimulation of primary microglia (A). Antibody to C-terminus reveals similar enhancement of protein after gp120 treatment (B) When normalized to actin and quantified using Image J densitometry software, PS2 holoprotein is increased by 41%, CTF by 92% PS2 N-terminus : APS 21 AbCam (12  g/ml), PS2 CTF : 2192 Cell Signaling (1:1000) WT mouse PS2 KO Specificity of PS2 antibody using PS2 KO mouse PS2 antibody employed in (A) labels glial cells in wildtype mice but not PS2 KO mouse (tissue gift from Dr. Reuven Stein) 1. PS2 is markedly increased in glial cells in AD brain A) PS2 (brown) immunolabeling is increased in the white matter (co-labeled with microglia marker CD68) of AD brain compared to age- matched control. B) Similar increase in immunopositivity is not seen for PS1 (brown) in AD brain compared to control (D). Both antibodies labeled neuron cell bodies in cortex. Control-PS2Control-PS2 AD-PS2AD-PS2 Control-PS1Control-PS1AD-PS1AD-PS1 Samples are autopsy tissue paraffin embedded slides obtained from Harborview Medical Center Pathology Department. Slides underwent antigen retrieval by microwave heating. PS2 antibody : 2192 Cell Signaling (1:50), PS1 antibody : APS 11 ABR (75  g/ml), CD68 antibody: DAKO (1:750) A) B) PS2 antibody : 2192 Cell Signaling (1:50), CD68 antibody: DAKO (1:750) HAD Control HAD Control 3. Microglia PS2 is increased in HIV Associated Dementia A) Paraffin embedded autopsy cortical tissue from control and HAD colabeled for PS2 (brown) and microglia (purple) demonstrate enhanced PS2 immunoreactivity in HAD brain, particularly in activated microglia (arrows). Ramified microglia with little PS2 immunoreactivity are seen in control (arrowhead). B) PS1 protein (brown, empty arrows) is not markedly increased in HAD compared to control. Samples are autopsy tissue paraffin embedded slides obtained from National NeuroAids Tissue Consortium. Slides underwent antigen retrieval by microwave heating. PS2 antibody : 2192 Cell Signaling (1:50), PS1 antibody : APS 11 ABR (75  g/ml), CD68 antibody: DAKO (1:750) A) B) A)B)